Is PHAT stock safe? | Glauxie AI

Q: Is PHAT stock safe?

Phathom Pharmaceuticals, Inc. (PHAT) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Steven L. Basta. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United... Employees: 371.

Q: What are the risks of investing in PHAT?

Identify key risks of investing in PHAT — debt, competition, volatility, and sector headwinds.

Q: Is PHAT a good long-term investment?

Evaluate PHAT as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does PHAT have?

Review PHAT total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is PHAT stock safe?

🦉

Phathom Pharmaceuticals, Inc. (PHAT)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOSteven L. Basta

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks...

Key Executives

Name	Title
Anne Marie Cook	Chief Legal Officer & Corporate Secretary
Azmi Nabulsi	Co-Founder
Bill Aprea	Senior Vice President, Chief Compliance Officer & Deputy Chief Legal Officer
David A. Socks	Co-Founder
Eckhard Leifke	Chief Medical Officer
Eric Sciorilli	Director of Business Development & Investor Relations

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

PHAT Profile Financials

What are the risks of investing in PHAT? Is PHAT a good long-term investment? How much debt does PHAT have?